tm
Seeing Is Believing
tm
Seeing Is Believing
LVTX is currently covered by 3 analysts with an average price target of $8.05. This is a potential upside of $6.8 (544%) from yesterday's end of day stock price of $1.25.
LAVA Therapeutics NV's activity chart (see below) currently has 5 price targets and 20 ratings on display. The stock rating distribution of LVTX is 76.92% BUY and 23.08% HOLD.
Analysts average stock forecasts to be materialized ratio is 5.56% with an average time for these price targets to be met of 25.67 days.
Highest price target for LVTX is $6, Lowest price target is $2, average price target is $4.
Most recent stock forecast was given by DAINA GRAYBOSCH from LEERINK on 11-Dec-2024. First documented stock forecast 18-Apr-2021.
Currently out of the existing stock ratings of LVTX, 10 are a BUY (76.92%), 3 are a HOLD (23.08%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2
$0.75 (60.00%)
5 months ago
(11-Dec-2024)
0/3 (0%)
$0.8 (66.67%)
Hold
$6
$4.75 (380.00%)
$6
5 months 1 days ago
(10-Dec-2024)
1/6 (16.67%)
$4.79 (395.87%)
77
Buy
$19
$17.94 (1692.45%)
$22
3 years 21 days ago
(20-Apr-2022)
0/2 (0%)
$14.82 (354.55%)
What is LVTX (LAVA Therapeutics NV) average time for price targets to be met?
Which analyst has the current highest performing score on LVTX (LAVA Therapeutics NV) with a proven track record?
Which analyst has the current lower performing score on LVTX (LAVA Therapeutics NV) with a proven track record?
Which analyst has the most public recommendations on LVTX (LAVA Therapeutics NV)?
Which analyst is the currently most bullish on LVTX (LAVA Therapeutics NV)?
Which analyst is the currently most reserved on LVTX (LAVA Therapeutics NV)?
